Can Helicobacter pylori-associated dyspepsia be categorized as functional dyspepsia?

Hidekazu Suzuki, Toshihiro Nishizawa, Toshifumi Hibi

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Evidence for an association between H. pylori and functional dyspepsia (FD) is uncertain. In the present review, we focused the special relevance of H. pylori infection to the development dyspepsia from the aspects of pathogensis, clinical efficacy of eradication of H. pylori in the West and in the East. Although clinical trials conducted to evaluate the efficacy of H. pylori eradication treatment for FD, including non-ulcer dyspepsia (NUD), have yielded conflicting results, it is quite clear that H. pylori eradication treatment is effective at least in a subset of FD patients. In contrast to the previous results obtained in studies of Western populations, the result of a double-blind, randomized, placebo-controlled trial conducted in a Singapore suggests that patients with FD could benefit from H. pylori eradication therapy, with as much as a 13-fold increase in the chance of symptom resolution. Especially in Asia, H. pylori should not be overlooked when considering the pathophysiology of FD. H. pylori-associated dyspepsia might be dealt as a different disease entity from FD.

Original languageEnglish
Pages (from-to)42-45
Number of pages4
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume26
Issue numberSUPPL. 3
DOIs
Publication statusPublished - 2011

Fingerprint

Dyspepsia
Helicobacter pylori
Singapore
Helicobacter Infections
Therapeutics
Randomized Controlled Trials
Placebos
Clinical Trials

Keywords

  • Acid
  • Asia
  • Eradication
  • Functional dyspepsia
  • Ghrelin
  • Helicobacter pylori
  • Meta-analysis
  • MicroRNA

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Can Helicobacter pylori-associated dyspepsia be categorized as functional dyspepsia? / Suzuki, Hidekazu; Nishizawa, Toshihiro; Hibi, Toshifumi.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 26, No. SUPPL. 3, 2011, p. 42-45.

Research output: Contribution to journalArticle

Suzuki, Hidekazu ; Nishizawa, Toshihiro ; Hibi, Toshifumi. / Can Helicobacter pylori-associated dyspepsia be categorized as functional dyspepsia?. In: Journal of Gastroenterology and Hepatology (Australia). 2011 ; Vol. 26, No. SUPPL. 3. pp. 42-45.
@article{2d24b5580fe543439eb924b30f5f29a7,
title = "Can Helicobacter pylori-associated dyspepsia be categorized as functional dyspepsia?",
abstract = "Evidence for an association between H. pylori and functional dyspepsia (FD) is uncertain. In the present review, we focused the special relevance of H. pylori infection to the development dyspepsia from the aspects of pathogensis, clinical efficacy of eradication of H. pylori in the West and in the East. Although clinical trials conducted to evaluate the efficacy of H. pylori eradication treatment for FD, including non-ulcer dyspepsia (NUD), have yielded conflicting results, it is quite clear that H. pylori eradication treatment is effective at least in a subset of FD patients. In contrast to the previous results obtained in studies of Western populations, the result of a double-blind, randomized, placebo-controlled trial conducted in a Singapore suggests that patients with FD could benefit from H. pylori eradication therapy, with as much as a 13-fold increase in the chance of symptom resolution. Especially in Asia, H. pylori should not be overlooked when considering the pathophysiology of FD. H. pylori-associated dyspepsia might be dealt as a different disease entity from FD.",
keywords = "Acid, Asia, Eradication, Functional dyspepsia, Ghrelin, Helicobacter pylori, Meta-analysis, MicroRNA",
author = "Hidekazu Suzuki and Toshihiro Nishizawa and Toshifumi Hibi",
year = "2011",
doi = "10.1111/j.1440-1746.2011.06629.x",
language = "English",
volume = "26",
pages = "42--45",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Can Helicobacter pylori-associated dyspepsia be categorized as functional dyspepsia?

AU - Suzuki, Hidekazu

AU - Nishizawa, Toshihiro

AU - Hibi, Toshifumi

PY - 2011

Y1 - 2011

N2 - Evidence for an association between H. pylori and functional dyspepsia (FD) is uncertain. In the present review, we focused the special relevance of H. pylori infection to the development dyspepsia from the aspects of pathogensis, clinical efficacy of eradication of H. pylori in the West and in the East. Although clinical trials conducted to evaluate the efficacy of H. pylori eradication treatment for FD, including non-ulcer dyspepsia (NUD), have yielded conflicting results, it is quite clear that H. pylori eradication treatment is effective at least in a subset of FD patients. In contrast to the previous results obtained in studies of Western populations, the result of a double-blind, randomized, placebo-controlled trial conducted in a Singapore suggests that patients with FD could benefit from H. pylori eradication therapy, with as much as a 13-fold increase in the chance of symptom resolution. Especially in Asia, H. pylori should not be overlooked when considering the pathophysiology of FD. H. pylori-associated dyspepsia might be dealt as a different disease entity from FD.

AB - Evidence for an association between H. pylori and functional dyspepsia (FD) is uncertain. In the present review, we focused the special relevance of H. pylori infection to the development dyspepsia from the aspects of pathogensis, clinical efficacy of eradication of H. pylori in the West and in the East. Although clinical trials conducted to evaluate the efficacy of H. pylori eradication treatment for FD, including non-ulcer dyspepsia (NUD), have yielded conflicting results, it is quite clear that H. pylori eradication treatment is effective at least in a subset of FD patients. In contrast to the previous results obtained in studies of Western populations, the result of a double-blind, randomized, placebo-controlled trial conducted in a Singapore suggests that patients with FD could benefit from H. pylori eradication therapy, with as much as a 13-fold increase in the chance of symptom resolution. Especially in Asia, H. pylori should not be overlooked when considering the pathophysiology of FD. H. pylori-associated dyspepsia might be dealt as a different disease entity from FD.

KW - Acid

KW - Asia

KW - Eradication

KW - Functional dyspepsia

KW - Ghrelin

KW - Helicobacter pylori

KW - Meta-analysis

KW - MicroRNA

UR - http://www.scopus.com/inward/record.url?scp=79953096246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953096246&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1746.2011.06629.x

DO - 10.1111/j.1440-1746.2011.06629.x

M3 - Article

C2 - 21443708

AN - SCOPUS:79953096246

VL - 26

SP - 42

EP - 45

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - SUPPL. 3

ER -